VF
PMVP icon

Virtu Financial’s PMV Pharmaceuticals PMVP Stock Holding History

Virtu Financial’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-14,050
Closed -$17K – 2105
2026
Q1 		$17K Buy
14,050
+1,208
+9% +$1.54K ﹤0.01% 1412
2025
Q4 		$16K Buy
+12,842
New +$17.2K ﹤0.01% 1460
2024
Q4 		– Sell
-28,146
Closed -$42K – 1929
2024
Q3 		$42K Buy
+28,146
New +$43.5K ﹤0.01% 1043
2024
Q1 		– Sell
-15,442
Closed -$48K – 1943
2023
Q4 		$48K Buy
+15,442
New +$40.9K ﹤0.01% 1177
2022
Q3 		– Sell
-26,378
Closed -$376K – 2119
2022
Q2 		$376K Buy
+26,378
New +$384K 0.03% 481

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Virtu Financial's PMVP Position: Q2 2026 in Review

Virtu Financial sold out of PMV Pharmaceuticals (PMVP) in Q2 2026, closing a stake of 14,050 shares — an estimated $17K sold.

Virtu Financial first reported a position in PMVP in Q2 2022 and held it in 5 quarters. The position peaked at $376K in Q2 2022. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Virtu Financial reported no remaining PMV Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 14,050 PMV Pharmaceuticals shares in Q2 2026, an estimated $17K.
  • Virtu Financial first reported a position in PMV Pharmaceuticals in Q2 2022 and held it in 5 quarters.
  • Virtu Financial's PMV Pharmaceuticals position peaked at $376K in Q2 2022.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.